WHO consensus statement.
Abas
M A
MA
Acuda
S W
SW
Broadhead
J C
JC
Chagwedera
I V
IV
Chikara
F B
FB
Piachaud
J M
JM
Stefanovio
M
M
Vermeulen
J
J
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D010276:Parasympatholytics